OHR Pharmaceutical Inc Share Price Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.38M 115M |
---|---|---|---|---|---|
Net income 2023 * | -12M -1B | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
1st Jan change | Capi. | |
---|---|---|
+29.32% | 49.18B | |
+0.99% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.64% | 26.09B | |
-22.72% | 18.71B | |
+8.42% | 13.26B | |
+32.20% | 12.32B | |
-0.74% | 11.99B |